Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
"Janssen, Clinician",Ustekinumab,"Psoriasis, chronic plaque, 1st line",Ustekinumab,Community and Hospital,Dermatologicals
